Search clinical trials for: Metastatic castrate resistant prostate cancer (CRPC)
Total 91496 results
-
AmgenCompletedCancer | Prostate Cancer | Castrate-Resistant Prostate Cancer | Mestastatic Prostate Cancer
-
Tianjin Medical University Second HospitalUnknownMetastatic Cancer | Castration-resistant Prostate CancerChina
-
DexTech Medical ABCompletedProstate Cancer MetastaticSweden
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
Dana-Farber Cancer InstituteTerminated
-
Tianjin Medical University Second HospitalTianjin Medical University General Hospital; Tianjin First Central Hospital; The...Not yet recruiting
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
DexTech Medical ABTerminatedProstate Cancer MetastaticSweden
-
Aragon Pharmaceuticals, Inc.Completed
-
Pengyuan LiuRecruitingMetastatic Castration-resistant Prostate Cancer (CRPC)China
-
DexTech Medical ABUnknownProstate Cancer MetastaticEstonia, Sweden, Finland, Latvia
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityCompletedCastration-resistant Prostate CancerChina
-
Tianjin Medical University Cancer Institute and...UnknownHormone Refractory Prostate CancerChina
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
Rahul AggarwalSanofiCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Edwin Posadas, MDEnviro Therapeutics, Inc.RecruitingCastration-resistant Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityRecruitingCastration-resistant Prostate CancerChina
-
Daiichi Sankyo, Inc.PlexxikonTerminatedProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...WithdrawnProstate Cancer | Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)United States
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Lawson Health Research InstituteOICRTerminatedProstate CancerCanada
-
Ospedale Andrea Tortora di PaganiUnknownCastration-resistant Prostate CancerItaly
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Donald Trump, MDTerminated
-
Tiltan Pharma Ltd.UnknownMetastatic Castration Resistant Prostate Cancer (CRPC)Israel
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
BIND TherapeuticsCompleted
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
Tianjin Medical University Second HospitalUnknown
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Bellicum PharmaceuticalsM.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaboratorsCompletedCastrate Resistant Prostate Cancer (CRPC)United States
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
Zhengzhou UniversityThe First Affiliated Hospital of Zhengzhou University; Xinyang Central Hospital and other collaboratorsUnknown
-
Boehringer IngelheimCompletedProstatic Neoplasms, Castration-ResistantKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Singapore, Hong Kong, Netherlands
-
GU Research Network, LLCChurchill Pharmaceutical LLCCompletedProstate CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingMetastatic Castrate-resistant Prostate (CRPC) CancerFrance
-
Pharmicell Co., Ltd.TerminatedCastration Resistant Prostate Cancer, CRPCKorea, Republic of
-
Immunic AGTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Dana-Farber Cancer InstituteCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Approved for marketingUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Neoplasms | Genital Diseases, MaleUnited States, Australia, Hong Kong, Spain, Colombia, Mexico, Poland, Malaysia, Romania, Canada, Greece, Taiwan, Korea, Republic of, New Zealand, Singapore, Brazil, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary and more
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Saladax Biomedical, Inc.UPMC CancerCenterCompletedProstate CancerUnited States
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Prostate Neoplasms | Castration Resistant Prostate Cancer (CRPC)Japan
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States